Physical Activity Recommendations for Bicuspid Aortic Valve

Eligibility for Competitive Sports

• Athletes with a bicuspid aortic valve who have normal valve function, normal left‑ventricular size, and an ascending aorta < 4.0 cm may participate in any competitive sport without restriction. 1

Valve‑Function Stratification

Aortic Stenosis

• Mild stenosis (peak jet < 3 m/s, mean gradient < 20 mmHg) – all competitive sports are permitted if exercise testing shows normal tolerance and blood‑pressure response. 1
• Moderate stenosis (peak jet 3–4 m/s, mean gradient 20–40 mmHg) – all competitive sports are permitted if exercise testing demonstrates normal tolerance. 1
• Severe stenosis (peak jet > 4 m/s, mean gradient > 40 mmHg) – competitive sports participation is prohibited. 1

Aortic Regurgitation

• Mild–moderate regurgitation with preserved left‑ventricular ejection fraction and no or mild dilation – all competitive sports allowed when exercise tolerance is normal. 1
• Mild–moderate regurgitation with moderate left‑ventricular dilation (LV end‑systolic dimension below sex‑specific thresholds) – competitive sports are reasonably allowed if exercise testing is normal. 1
• Severe regurgitation with symptoms, left‑ventricular ejection fraction < 50 % or marked dilation – competitive sports are prohibited. 1

Left‑Ventricular Dimension Thresholds (independent of valve function)

• Men: LV end‑diastolic dimension > 70 mm or LV end‑systolic dimension > 49 mm triggers restriction. 1
• Women: LV end‑diastolic dimension > 60 mm or LV end‑systolic dimension > 38 mm triggers restriction. 1
• Indexed to body surface area: LV end‑diastolic dimension > 35.3 mm/m² (men) or > 40.8 mm/m² (women) triggers restriction. 1
• Athletic training can produce physiologic LV enlargement; dimensions exceeding typical athlete norms (e.g., >70 mm in men) are more likely pathologic and warrant restriction. 2

Ascending Aorta Size – Primary Determinant of Activity Level

Exercise Testing Requirements

• Annual maximal exercise testing (to the level of intended competition) is mandatory for all athletes with a bicuspid aortic valve, evaluating:
• Abnormal findings on testing can modify activity recommendations even when resting echocardiography appears acceptable. 1

Surveillance Protocol

• Annual clinical evaluation for all sport‑participating patients, including history, physical examination, Doppler echocardiography (valve function, LV dimensions, aortic size) and maximal exercise testing. [1][2]
• Imaging intervals for aortic surveillance:

Isometric (Heavy‑Static) Exercise Guidance

• The 2015 AHA/ACC guideline advises caution with high‑static activities when the aorta is ≥ 4.0 cm, recommending restriction from high‑static sports. 1
• For patients with aortic diameter < 4.0 cm and normal valve function, isometric exercise may be permitted provided annual surveillance is maintained. 1

Risk of Dissection and Common Pitfalls

• Over‑restriction can affect > 35 % of school‑age children with bicuspid aortic valve, yet the absolute risk of aortic dissection under routine surveillance is low (≈ 0.4 %). 4
• Dissection may occur at smaller diameters in bicuspid valves (mean ≈ 5.1 cm) compared with tricuspid valves. [5][6]
• When aortic dimensions approach 4.5 cm or are not clearly visualized on transthoracic echo, advanced imaging (MRI/CT) should be obtained.
• Average aortic dilation progression is 0.5–0.9 mm/yr; rapid growth (> 0.5 cm/yr) mandates surgical referral even at smaller absolute diameters. 4

Bicuspid Aortic Valve Management

Valve Replacement Indications

• The American Heart Association recommends operating on patients with symptomatic severe aortic stenosis or regurgitation, as evidenced by exertional dyspnea, angina, dizziness, or syncope 7
• The European Society of Cardiology suggests operating when left ventricular ejection fraction decline or significant LV diameter changes approaching intervention thresholds are observed 8, 9
• Valve replacement is recommended when undergoing concurrent cardiac surgery, such as CABG or mitral valve surgery, even with moderate aortic valve dysfunction 8, 9

Ascending Aorta Management During Valve Replacement

• The American College of Cardiology recommends simultaneously replacing the ascending aorta if its diameter exceeds 4.5 cm during aortic valve replacement for severe stenosis or regurgitation 10, 11, 7

Isolated Ascending Aorta Surgery

• The American Heart Association suggests operating on isolated ascending aortic aneurysms without significant valve dysfunction at a diameter of 5.5 cm in patients without additional risk factors 10, 11
• A lower threshold of 5.0 cm is recommended when risk factors such as family history of aortic dissection, rapid aortic growth, aortic coarctation, resistant hypertension, age <50 years, or desire for pregnancy are present 10, 11, 12

Surveillance Protocol

• The European Society of Cardiology recommends annual clinical visits with echocardiography every 2 years for patients with mild-to-moderate valve dysfunction 8, 9
• For severe valve dysfunction with normal LV function, initial 6-month follow-up, then 6-month intervals if parameters are changing, or yearly if stable 8, 9
• Annual imaging with echocardiography, MRI, or CT is recommended for ascending aorta diameters >4.0 cm 10, 11, 7, 12

Medical Management

• The American College of Cardiology states that no proven medical therapies exist to reduce progression of bicuspid aortic valve-associated aortopathy, but controlling hypertension with any effective antihypertensive agent is recommended 11
• Beta-blockers and ARBs have theoretical advantages but lack proven benefit in clinical studies for slowing aortic dilation 11, 9
• Immediate smoking cessation is mandated, as smoking doubles the rate of aneurysm expansion 12

Surveillance and Surgical Thresholds for Ascending Aortic Dilatation

Imaging Frequency and Modality

Surgical Intervention Thresholds

Monitoring Parameters Influencing Management

Risk Estimates